These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26390698)

  • 21. [miR-143 inhibits cell proliferation through targeted regulating the expression of K-ras gene in HeLa cells].
    Qin HX; Cui HK; Pan Y; Hu RL; Zhu LH; Wang SJ
    Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):893-897. PubMed ID: 27998464
    [No Abstract]   [Full Text] [Related]  

  • 22. MiR-634 sensitizes nasopharyngeal carcinoma cells to paclitaxel and inhibits cell growth both in vitro and in vivo.
    Peng X; Cao P; He D; Han S; Zhou J; Tan G; Li W; Yu F; Yu J; Li Z; Cao K
    Int J Clin Exp Pathol; 2014; 7(10):6784-91. PubMed ID: 25400759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-630 inhibitor sensitizes chemoresistant ovarian cancer to chemotherapy by enhancing apoptosis.
    Eoh KJ; Lee SH; Kim HJ; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
    Biochem Biophys Res Commun; 2018 Mar; 497(2):513-520. PubMed ID: 29452092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-143 replenishment re-sensitizes colorectal cancer cells harboring mutant, but not wild-type, KRAS to paclitaxel treatment.
    Fei BY; Wang XY; Fang XD
    Tumour Biol; 2016 May; 37(5):5829-35. PubMed ID: 26581910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-186 induces sensitivity of ovarian cancer cells to paclitaxel and cisplatin by targeting ABCB1.
    Sun KX; Jiao JW; Chen S; Liu BL; Zhao Y
    J Ovarian Res; 2015 Dec; 8():80. PubMed ID: 26626440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-138 is a potential biomarker and tumor suppressor in human cervical carcinoma by reversely correlated with TCF3 gene.
    Li H; Sheng Y; Zhang Y; Gao N; Deng X; Sheng X
    Gynecol Oncol; 2017 Jun; 145(3):569-576. PubMed ID: 28385388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-873 mediates multidrug resistance in ovarian cancer cells by targeting ABCB1.
    Wu DD; Li XS; Meng XN; Yan J; Zong ZH
    Tumour Biol; 2016 Aug; 37(8):10499-506. PubMed ID: 26850595
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer.
    Xu J; Li Y; Wang F; Wang X; Cheng B; Ye F; Xie X; Zhou C; Lu W
    Oncogene; 2013 Feb; 32(8):976-87. PubMed ID: 22469983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Study on effects of microRNA-21 antisense oligonucleotide in vivo and in vitro on bionomics of human cervical squamous carcinoma cell lines SiHa].
    Wang XM; Xu J; Cheng ZQ; Peng QZ; Hu JT; Gao LK; Zhang SF; Jin HT
    Zhonghua Bing Li Xue Za Zhi; 2012 Apr; 41(4):254-9. PubMed ID: 22800522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-27b up-regulated by human papillomavirus 16 E7 promotes proliferation and suppresses apoptosis by targeting polo-like kinase2 in cervical cancer.
    Liu F; Zhang S; Zhao Z; Mao X; Huang J; Wu Z; Zheng L; Wang Q
    Oncotarget; 2016 Apr; 7(15):19666-79. PubMed ID: 26910911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line.
    Xu CZ; Xie J; Jin B; Chen XW; Sun ZF; Wang BX; Dong P
    Int J Clin Exp Pathol; 2013; 6(7):1351-61. PubMed ID: 23826416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton Pump Inhibition Enhances the Cytotoxicity of Paclitaxel in Cervical Cancer.
    Song T; Jeon HK; Hong JE; Choi JJ; Kim TJ; Choi CH; Bae DS; Kim BG; Lee JW
    Cancer Res Treat; 2017 Jul; 49(3):595-606. PubMed ID: 27669706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA-7-5p Promotes Cisplatin Resistance of Cervical Cancer Cells and Modulation of Cellular Energy Homeostasis by Regulating the Expression of the PARP-1 and BCL2 Genes.
    Yang F; Guo L; Cao Y; Li S; Li J; Liu M
    Med Sci Monit; 2018 Sep; 24():6506-6516. PubMed ID: 30219819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
    Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
    Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decrease of let-7f in low-dose metronomic Paclitaxel chemotherapy contributed to upregulation of thrombospondin-1 in breast cancer.
    Tao WY; Liang XS; Liu Y; Wang CY; Pang D
    Int J Biol Sci; 2015; 11(1):48-58. PubMed ID: 25552929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
    Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
    Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor.
    Luo M; Shen D; Zhou X; Chen X; Wang W
    Surgery; 2013 Jun; 153(6):836-47. PubMed ID: 23453369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clusterin confers paclitaxel resistance in cervical cancer.
    Park DC; Yeo SG; Shin EY; Mok SC; Kim DH
    Gynecol Oncol; 2006 Dec; 103(3):996-1000. PubMed ID: 16890274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-101-5p inhibits the growth and metastasis of cervical cancer cell by inhibiting CXCL6.
    Shen W; Xie XY; Liu MR; Wang LL
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1957-1968. PubMed ID: 30915738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.